| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.65B | 45.67B | 45.11B | 44.09B | 39.57B | 36.91B |
| Gross Profit | 17.70B | 17.66B | 17.75B | 17.77B | 13.96B | 13.79B |
| EBITDA | 9.10B | 9.33B | 9.19B | 9.48B | 6.20B | 6.49B |
| Net Income | 4.74B | 4.70B | 4.83B | 5.12B | 2.74B | 2.53B |
Balance Sheet | ||||||
| Total Assets | 65.90B | 68.70B | 67.41B | 64.31B | 64.77B | 61.41B |
| Cash, Cash Equivalents and Short-Term Investments | 21.91B | 23.24B | 22.60B | 20.43B | 23.59B | 22.39B |
| Total Debt | 431.00M | 178.00M | 245.00M | 508.00M | 255.00M | 527.00M |
| Total Liabilities | 13.20B | 12.43B | 13.99B | 13.51B | 14.80B | 13.62B |
| Stockholders Equity | 51.94B | 55.45B | 52.69B | 50.13B | 49.38B | 47.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.55B | 4.82B | 1.81B | 2.21B | 4.30B |
| Operating Cash Flow | 0.00 | 7.08B | 7.53B | 4.67B | 4.00B | 6.04B |
| Investing Cash Flow | 0.00 | -4.15B | -3.55B | -3.17B | -1.97B | -1.91B |
| Financing Cash Flow | 0.00 | -2.70B | -2.64B | -4.95B | -979.00M | -937.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥119.95B | 7.55 | ― | 1.61% | 5.13% | 72.55% | |
77 Outperform | ¥52.02B | 14.50 | ― | 4.44% | 1.24% | -2.98% | |
77 Outperform | ¥271.15B | 13.32 | ― | 1.53% | 9.71% | 54.82% | |
74 Outperform | ¥128.74B | 7.89 | 8.07% | 2.64% | 81.06% | 65.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥56.10B | -60.12 | ― | 5.01% | -25.54% | -166.77% | |
58 Neutral | ¥44.36B | 11.47 | ― | 0.91% | 11.44% | -4.29% |